Get the latest news and blog posts from APCI, including press releases and articles about advocacy actions, industry happenings, clinical pharmacy information, independent pharmacy operations, and much more.
APCI’s Greg Reybold and 3 Axis Advisors’ Antonio Ciaccia examine PBM savings claims, drug pricing research, and the financial incentives behind prescription costs.
PBMs negotiate billions in rebates and discounts from drug manufacturers, but patients rarely see those savings at the pharmacy counter.
Federal audits raise questions about whether TRICARE receives all negotiated pharmacy savings and whether military families benefit from policies favoring mail order.
An audit’s scope determines what it can uncover. Pharmacy payment comparisons need to capture what happens after a prescription is filled.
A practical guide to comparing buying groups on economics, service, support, ownership, and the long‑term value they bring to an independent pharmacy.
Iowa’s PBM reform fight shows how pharmacists can help shape policy, build legislative support, and defend reforms after they become law.
APCI is seeing an increasing number of social media replies defending PBM practices. Where is this sudden interest in PBMs coming from?
Four federal audits reveal how negotiated savings failed to reach health plans and why APCI is calling for enforceable payment rules.
TRICARE’s shrinking pharmacy network raises questions about patient choice, rural access, and whether current standards truly measure meaningful pharmacy access.
H.R. 6610 has cleared committee with overwhelming bipartisan support. Now independent pharmacy needs Congress to keep the Pharmacists Fight Back Act moving.